A Randomized Trial of Clozapine Versus Other Antipsychotics for Cannabis Use Disorder in Patients With Schizophrenia

REFERENCES

• Akerele , E. and Levin , F. R. 2007 . Comparison of olanzapine to risperidone in substance-abusing individuals with schizophrenia . American Journal on Addictions , 16 ( 4 ) : 260 – 268 .
   PubMed Web of Science ®Google Scholar
• Albanese , M. J. , Khantzian , E. J. , Murphy , S. L. and Green , A. I. 1994 . Decreased substance use in chronically psychotic patients treated with clozapine . American Journal of Psychiatry , 151 : 780 – 781 .
   PubMed Web of Science ®Google Scholar
• Alterman , A. J. , Erdlen , F. R. and Murphy , E. 1981 . Alcohol abuse in the psychiatric hospital population . Addictive Behaviors , 6 : 69 – 73 .
   PubMed Web of Science ®Google Scholar
• Amodei , N. and Lamb , R. J. 2004 . Convergent and concurrent validity of the Contemplation Ladder and URICA scales . Drug and Alcohol Dependence , 73 ( 3 ) : 301 – 306 .
   PubMed Web of Science ®Google Scholar
• Ananth , J. , Vandewater , S. , Kamal , M. , Brodsky , A. , Gamal , R. and Miller , M. 1989 . Missed diagnosis of substance abuse in psychiatric patients . Hospital & Community Psychiatry , 40 : 297 – 299 .
   PubMedGoogle Scholar
• Andreasen , N. C. 1982 . Negative symptoms in schizophrenia . Archives of General Psychiatry , 39 : 784 – 788 .
   PubMed Web of Science ®Google Scholar
• Antelman , S. M. and Caggiula , A. R. 1977 . Norepinephrine-dopamine interactions and behavior . Science , 195 ( 4279 ) : 646 – 653 .
   PubMed Web of Science ®Google Scholar
• Barnes , T. R. 1989 . A rating scale for drug-induced akathisia . The British Journal of Psychiatry , 154 : 672 – 676 .
   PubMed Web of Science ®Google Scholar
• Beresford , T. P. , Clapp , L. , Martin , B. , Wiberg , J. L. , Alfers , J. and Beresford , H. F. 2005 . Aripiprazole in schizophrenia with cocaine dependence: A pilot study . Journal of Clinical Psychiatry , 25 ( 4 ) : 363 – 366 .
   Web of Science ®Google Scholar
• Breier , A. , Buchanan , R. W. , Waltrip , R. W. 2nd , Listwak , S. , Holmes , C. and Goldstein , D. S. 1994 . The effect of clozapine on plasma norepinephrine: Relationship to clinical efficacy . Neuropsychopharmacology , 10 ( 1 ) : 1 – 7 .
   PubMed Web of Science ®Google Scholar
• Brown , E. S. , Jeffress , J. , Liggin , J. D. M. , Garza , M. and Beard , L. 2005 . Switching outpatients with bipolar or schizoaffective disorders and substance abuse from their current antipsychotic to aripiprazole . Journal of Clinical Psychiatry , 66 ( 6 ) : 756 – 760 .
   PubMed Web of Science ®Google Scholar
• Brown , E. S. , Nejtek , V. A. , Perantie , D. C. , Rajan Thomas , N. and Rush , A. J. 2003 . Cocaine and amphetamine use in patients with psychiatric illness: A randomized trial of typical antipsychotic continuation or discontinuation . Journal of Clinical Psychopharmacology , 23 ( 4 ) : 384 – 388 .
   PubMed Web of Science ®Google Scholar
• Brunette , M. F. , Drake , R. E. , Xie , H. , McHugo , G. J. and Green , A. I. 2006 . Clozapine use and relapses of substance use disorder among patients with co-occurring schizophrenia and substance use disorders . Schizophrenia Bulletin , : 32 – 38 .
   Google Scholar
• Brunette , M. F. , O’Keefe , C. , Dawson , R. , Buckley , P. and Green , A. I. 2009 . An open label study of quetiapine in patients with schizophrenia and alcohol disorders . Journal of Mental Health and Substance Use Disorders , 2 ( 3 ) : 203 – 211 .
   Google Scholar
• Brunette , M. F. , O’Keefe , C. , Zimmet , S. , Wojcik , J. D. , Dawson , R. and Green , A. I. 2008 . Olanzapine for alcohol use disorder in patients with schizophrenia . Journal of Dual Diagnosis , 4 ( 4 ) : 344 – 354 .
   Web of Science ®Google Scholar
• Buckley , P. , McCarthy , M. , Chapman , P. , Richman , C. and Yamamoto , B. 1999 . Clozapine treatment of comorbid substance abuse in patients with schizophrenia . Schizophrenia Research , 36 : 272
   Web of Science ®Google Scholar
• Byerly , M. J. , Thompson , A. , Carmody , T. , Bugno , R. , Ervin , T. , Kashner , M. and Rush , A. J. 2007 . Validity of electronically monitored medication adherence and conventional adherence measures in schizophrenia . Psychiatric Services , 58 : 844 – 847 .
   PubMed Web of Science ®Google Scholar
• Clark , R. , Teague , G. , Ricketts , S. , Bush , P. , Zubkoff , M. and Keller , A. 1994 . Measuring resource use in economic evaluations: Determining the social costs of mental illness . Journal of Mental Health Administration , 21 : 32 – 41 .
   PubMedGoogle Scholar
• DeQuardo , J. R. , Carpenter , C. F. and Tandon , R. 1994 . Patterns of substance abuse in schizophrenia: Nature and significance . Journal of Psychiatric Research , 28 ( 3 ) : 267 – 275 .
   PubMed Web of Science ®Google Scholar
• Dickey , B. and Azeni , H. 1996 . Persons with dual diagnoses of substance abuse and major mental illness: Their excess costs of psychiatric care . American Journal of Public Health , 86 : 973 – 977 .
   PubMed Web of Science ®Google Scholar
• Dixon , L. , Haas , G. , Weiden , P. J. , Sweeney , J. and Frances , A. J. 1991 . Drug abuse in schizophrenic patients: Clinical correlates and reasons for use . American Journal of Psychiatry , 148 : 224 – 230 .
   PubMed Web of Science ®Google Scholar
• Drake , R. E. , Mueser , K. T. , Brunette , M. F. and McHugo , G. J. 2004 . A review of treatment for people with severe mental illness and co-occurring substance use disorders . Psychchiatricl Rehabilitation Journal , 27 ( 4 ) : 360 – 374 .
   PubMed Web of Science ®Google Scholar
• Drake , R. E. , Xie , H. , McHugo , G. J. and Green , A. I. 2000 . The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia . Schizophrenia Bulletin , 26 ( 2 ) : 441 – 449 .
   PubMed Web of Science ®Google Scholar
• First , M. B. , Spitzer , R. L. , Gibbon , M. and Williams , J. B. W. 1996 . Structured Clinical Interview for DSM-IV Axis-I Disorders–Patient Edition (SCID-I/P, Version 2.0) , New York , NY : Biometrics Research Department .
   Google Scholar
• Freed , E. X. 1975 . Alcoholism and schizophrenia: The search for perspectives . Journal of Studies on Alcohol , 36 ( 7 ) : 853 – 881 .
   PubMed Web of Science ®Google Scholar
• Gardner , D. M. , Murphy , A. L. , O’Donnell , H. , Centorrino , F. and Baldessarini , R. J. 2010 . International consensus study of antipsychotic dosing . American Journal of Psychiatry , 167 ( 6 ) : 686 – 693 .
   PubMed Web of Science ®Google Scholar
• George , T. P. , Sernyak , M. J. , Ziedonis , D. and Woods , S. M. 1995 . Effects of clozapine on smoking in chronic schizophrenic outpatients . Journal of Clinical Psychiatry , 56 ( 8 ) : 344 – 346 .
   PubMed Web of Science ®Google Scholar
• Green , A. I. , Alam , M. Y. , Sobieraj , J. T. , Pappalardo , K. M. , Waternaux , C. , Salzman , C. and …Schildkraut , J. J. 1993 . Clozapine response and plasma catecholamines and their metabolites . Psychiatry Research , 46 ( 2 ) : 139 – 149 .
   PubMed Web of Science ®Google Scholar
• Green , A. I. , Burgess , E. S. , Dawson , R. , Zimmet , S. V. and Strous , R. D. 2003 . Alcohol and cannabis use in schizophrenia: Effects of clozapine vs. risperidone . Schizophrenia Research , 60 ( 1 ) : 81 – 85 .
   PubMed Web of Science ®Google Scholar
• Green , A. I. , Noordsy , D. L. , Brunette , M. F. and O’Keefe , C. 2008 . Substance abuse and schizophrenia: Pharmacotherapeutic intervention . Journal of Substance Abuse Treatment , 34 ( 1 ) : 61 – 71 .
   PubMed Web of Science ®Google Scholar
• Green , A. I. , Zimmet , S. V. , Strous , R. D. and Schildkraut , J. J. 1999 . Clozapine for comorbid substance use disorder and schizophrenia: Do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine? . Harvard Review of Psychiatry , 6 ( 6 ) : 287 – 296 .
   PubMed Web of Science ®Google Scholar
• Guy , W. 1976 . ECDEU Assessment Manual for Psychopharmacology , Rockville , MD : U.S. Department of Health, Education and Welfare .
   Google Scholar
• Hambrecht , M. and Hafner , H. 1996 . Substance abuse and the onset of schizophrenia . Biological Psychiatry , 40 ( 11 ) : 1155 – 1163 .
   PubMed Web of Science ®Google Scholar
• Kessler , R. C. , Birnbaum , H. , Demler , O. , Falloon , I. R. H. , Gagnon , E. , Guyer , M. and …Wu , E. Q. 2005 . The prevalence and correlates of nonaffective psychosis in the National Comorbidity Survey Replication (NCS-R) . Biological Psychiatry , 58 ( 8 ) : 668 – 676 .
   PubMed Web of Science ®Google Scholar
• Kessler , R. C. , McGonagle , K. A. , Zhao , S. , Nelson , C. B. , Hughes , M. , Eshleman , S. and …Kendler , K. S. 1994 . Lifetime and 12 month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey . Archives of General Psychiatry , 51 ( 1 ) : 8 – 19 .
   PubMed Web of Science ®Google Scholar
• Kivlahan , D. R. , Heiman , J. R. , Wright , R. C. , Mundt , J. W. and Shupe , J. A. 1991 . Treatment cost and rehospitalization rate in schizophrenic outpatients with a history of substance abuse . Hospital & Community Psychiatry , 42 ( 6 ) : 609 – 614 .
   PubMedGoogle Scholar
• Knudsen , P. and Vilmar , T. 1984 . Cannabis and neuroleptic agents in schizophrenia . Acta Psychiatrica Scandinavica , 69 : 162 – 174 .
   PubMed Web of Science ®Google Scholar
• Koskinen , J. , Lohonen , J. , Koponen , H. , Isohanni , M. and Miettunen , J. 2010 . Rate of cannabis use disorders in clinical samples of patients with schizophrenia: A meta-analysis . Schizophrenia Bulletin , 36 ( 6 ) : 1115 – 1130 .
   PubMed Web of Science ®Google Scholar
• Laird , N. M. and Ware , J. H. 1982 . Random effects models for longitudinal data . Biometrics , 38 : 963 – 974 .
   PubMed Web of Science ®Google Scholar
• Lane , R. D. , Glazer , W. M. , Hansen , T. E. , Berman , W. H. and Kramer , S. I. 1985 . Assessment of tardive dyskinesia using the Abnormal Involuntary Movement Scale . Journal of Nervous and Mental Disease , 173 ( 6 ) : 353 – 357 .
   PubMed Web of Science ®Google Scholar
• Lee , M. L. 1998 . Clozapine and substance abuse in patients with schizophrenia . Canadian Journal of Psychiatry , 45 : 855 – 856 .
   Google Scholar
• Lieberman , J. , Johns , C. , Pollack , S. , Masiar , S. , Bookstein , P. , Cooper , T. and …Kane , J. 1991 . “ Biochemical effects of clozapine in cerebrospinal fluid of patients with schizophrenia ” . In Advances in neuropsychiatry and psychopharmacology vol. 1: Schizophrenia research , Edited by: Tamminga , C. and Schulz , S. 341 – 349 . New York , NY : Raven Press .
   Google Scholar
• Linszen , D. , Dingemans , P. and Lenior , M. 1994 . Cannabis abuse and the course of recent onset schizophrenic disorders . Archives of General Psychiatry , 51 : 273 – 279 .
   PubMed Web of Science ®Google Scholar
• Lukoff , K. , Liberman , R. and Nuechterlein , K. 1986 . Symptom monitoring in the rehabilitation of schizophrenic patients . Schizophrenia Bulletin , 12 : 578 – 602 .
   PubMed Web of Science ®Google Scholar
• Marcus , P. and Snyder , R. 1995 . Reduction of comorbid substance abuse with clozapine (letter) . American Journal of Psychiatry , 152 : 959
   PubMed Web of Science ®Google Scholar
• McEvoy , J. P. , Freudenreich , O. , Levin , E. and Rose , J. E. 1995 . Haloperidol increases smoking in patients with schizophrenia . Psychopharmacology , 119 : 124 – 126 .
   PubMed Web of Science ®Google Scholar
• McHugo , G. J. , Drake , R. E. , Burton , H. L. and Ackerson , T. H. 1995 . A scale for assessing the stage of substance abuse treatment in persons with severe mental illness . Journal of Nervous & Mental Disease , 183 ( 12 ) : 762 – 767 .
   PubMed Web of Science ®Google Scholar
• Mueser , K. T. , Bennett , M. and Kushner , M. G. 1995 . “ Epidemiology of substance use disorders among persons with chronic mental illness ” . In Double jeopardy: Chronic mental illness and substance use disorders , Edited by: Lehman , A. F. and Dixon , L. B. 9 – 25 . New York , NY : Harwood .
   Google Scholar
• Mueser , K. T. , Yarnold , P. R. , Levinson , D. F. , Singh , H. , Bellack , A. S. , Kee , K. and …Yadalam , K. G. 1990 . Prevalence of substance abuse in schizophrenia: Demographic and clinical correlates . Schizophrenia Bulletin , 16 : 31 – 56 .
   PubMed Web of Science ®Google Scholar
• Negrete , J. C. , Knapp , W. P. , Douglas , D. E. and Smith , W. B. 1986 . Cannabis affects the severity of schizophrenic symptoms: Results of a clinical survey . Psychology Medicine , 16 : 515 – 520 .
   PubMed Web of Science ®Google Scholar
• Noordsy , D. L. , O’Keefe , C. , Mueser , K. T. and Xie , H. 2001 . Six-month outcomes for patients who switched to olanzapine treatment . Psychiatric Services , 52 ( 4 ) : 501 – 507 .
   PubMed Web of Science ®Google Scholar
• Peralta , V. and Cuesta , M. J. 1992 . Influence of cannabis abuse on schizophrenic psychopathology . Acta Psychiatrica Scandinavica , 85 ( 2 ) : 127 – 130 .
   PubMed Web of Science ®Google Scholar
• Petrakis , I. L. , Leslie , D. , Finney , J. W. and Rosenheck , R. 2006 . Atypical antipsychotic medication and substance use-related outcomes in the treatment of schizophrenia . The American Journal on Addictions , 15 ( 1 ) : 44 – 49 .
   PubMed Web of Science ®Google Scholar
• Potvin , S. , Stip , E. , Lipp , O. , Elie , R. , Mancinin-Marie , A. , Demers , M. F. and …Gendron , A. 2006 . Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: An open-label trial . Current Medical Research and Opinion , 22 ( 7 ) : 1277 – 1285 .
   PubMed Web of Science ®Google Scholar
• Regier , D. A. , Farmer , M. E. , Rae , D. S. , Locke , B. Z. , Keith , S. J. , Judd , L. L. and Goodwin , F. K. 1990 . Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study [comment] . Journal of the American Medical Association , 264 ( 19 ) : 2511 – 2518 .
   PubMed Web of Science ®Google Scholar
• Rice , H. E. , Smith , C. B. , Silk , K. R. and Rosen , J. 1984 . Platelet alpha 2-adrenergic receptors in schizophrenic patients before and after phenothiazine treatment . Psychiatry Research , 12 ( 1 ) : 69 – 77 .
   PubMed Web of Science ®Google Scholar
• Sarafoff , M. , Davis , L. and Ruther , E. 1979 . Clozapine induced increase of human plasma norepinephrine . Journal of Neural Transmission , 46 ( 2 ) : 175 – 180 .
   PubMed Web of Science ®Google Scholar
• Simpson , G. N. and Angus , J. W. S. 1970 . A rating scale for extrapyramidal side effects . Acta Psychiatrica Scandinavica , 212 ( suppl. 44 ) : 11 – 19 .
   Google Scholar
• Smelson , D. A. , Losonczy , M. F. , Davis , C. W. , Kaune , M. , Williams , J. and Ziedonis , D. 2002 . Risperidone decreases craving and relapses in individuals with schizophrenia and cocaine dependence . Canadian Journal of Psychiatry , 47 ( 7 ) : 671 – 675 .
   PubMed Web of Science ®Google Scholar
• Smelson , D. A. , Williams , J. , Ziedonis , D. , Sussner , B. D. , Losonczy , M. F. , Engelhart , C. and Kaune , M. 2004 . A double-blind placebo-controlled pilot study of risperidone for decreasing cue-elicited craving in recently withdrawn cocaine dependent patients . Journal of Substance Abuse Treatment , 27 ( 1 ) : 45 – 49 .
   PubMed Web of Science ®Google Scholar
• Smelson , D. A. , Ziedonis , D. , Williams , J. , Losonczy , M. F. , Steinberg , M. L. and Kaune , M. 2006 . The efficacy of olanzapine for decreasing cue-elicited craving in individuals with schizophrenia and cocaine dependence: A preliminary report . Journal of Clinical Psychopharmacology , 26 ( 1 ) : 9 – 12 .
   PubMed Web of Science ®Google Scholar
• Sobell , M. B. , Maisto , S. A. , Sobell , L. C. , Cooper , A. M. , Cooper , T. and Saungers , B. 1980 . “ Developing a prototype for evaluating alcohol treatment effectiveness ” . In Evaluating alcohol and drug abuse treatment effectiveness: Recent advances , Edited by: Sobell , L. C. , Sobell , M. B. and Ward , E. 129 – 150 . New York , NY : Pergamon .
   Google Scholar
• Sobell , L. C. and Sobell , M. B. 1992 . “ Timeline Follow-Back: A technique for assessing self-reported alcohol consumption ” . In Measuring alcohol consumption: Psychosocial and biological methods , Edited by: Litten , R. Z. and Allen , J. 41 – 72 . Totowa , NJ : Humana Press .
   Google Scholar
• Svensson , T. H. , Mathe , J. M. , Andersson , J. L. , Nomikos , G. G. , Hildebrand , B. E. and Marcus , M. 1995 . Mode of action of atypical neuroleptics in relation to the phencyclidine model of schizophrenia: Role of 5-HT2 receptor and alpha 1-adrenoceptor antagonism . Journal of Clinical Psychopharmacology , 15 ( 1, suppl. 1 ) : 11S – 18S .
   PubMed Web of Science ®Google Scholar
• Thierry , A. M. , Godbout , R. , Mantz , J. and Glowinski , J. 1990 . Influence of the ascending monoaminergic systems on the activity of the rat prefrontal cortex . Progress in Brain Research , 85 : 357 – 364 . discussion 364–355
   PubMed Web of Science ®Google Scholar
• Treffert , D. A. 1978 . Marijuana use in schizophrenia: A clear hazard . American Journal of Psychiatry , 135 ( 10 ) : 1213 – 1215 .
   PubMed Web of Science ®Google Scholar
• Van Kammen , D. P. , Peters , J. L. , Van Kammen , W. B. , Neylan , T. , Yao , J. K. , Shaw , D. and Doherty , G. 1990 . “ Noradrenaline, state dependency and relapse prediction in schizophrenia ” . In International perspectives in schizophrenia , Edited by: Weller , M. 253 – 268 . London , , England : John Libbey .
   Google Scholar
• Warsi , M. , Sattar , S. P. , Bhatia , S. C. and Petty , F. 2005 . Aripiprazole reduces alcohol use . Canadian Journal of Psychiatry , 50 ( 4 ) : 244
   PubMed Web of Science ®Google Scholar
• Xie , H. , McHugo , G. J. , Fox , M. and Drake , R. E. 2005 . Substance abuse relapses in a 10-year prospective follow-up of clients with co-occurring severe mental illness and substance use disorders . Psychiatric Services , 56 : 1282 – 1287 .
   PubMed Web of Science ®Google Scholar
• Yovell , Y. and Opler , L. A. 1994 . Clozapine reverses cocaine craving in a treatment-resistant mentally ill chemical abuser: A case report and a hypothesis . Journal of Nervous Mental Disorders , 182 : 591 – 592 .
   PubMed Web of Science ®Google Scholar
• Zimmet , S. V. , Strous , R. D. , Burgess , E. S. , Kohnstamm , S. and Green , A. I. 2000 . Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: A retrospective survey . Journal of Clinical Psychopharmacology , 20 : 94 – 98 .
   PubMed Web of Science ®Google Scholar